Antidepressants Flashcards

(64 cards)

1
Q

Important early evidence for Monoamine theory came from the observation that reserpine, which inhibits ___ and ____ storage, depressed mood.

A

NA (noradrenaline)

5-HT (serotonin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Initially, the monoamine theory was formulated for ____, but the emphasis for Monoamine theory has since shifted towards _____.

A
  1. NA

2. 5-HT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where is Monoamine oxidase (MAO) found in the human body?

A

Found in nearly all tissues, including nerve terminals, intestine, and liver.
Found intracellularly, mostly on the mitochondrial surface

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

There are 2 major forms of MAO.

Neurochemical _____ is mainly broken down by MAO-A.

A

5-HT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which MAO form acts on NA and dopamine?

A

Both forms of MAO act on NA and dopamine and have equal selectivity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

MAO-B selective inhibitors (i.e. selegiline) are used in _________.

A

Parkinson’s disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which part of the synapse is MAO found at the synaptic junction?

A

Pre-synapse (intraceullarly)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Effect of MAO-inhibitors on monoamines?

A

Increased biological availability of monoamines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Phenelzine is more/less/non selective for MAO-A vs MAO-B.

A

Non-selective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Phenelzine is more/less/non selective for MAO-A vs MAO-B.

A

Non-selective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the adverse effects of MAO inhibitors?

A
  1. Postural Hypotension

2. Restlessness and insomnia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MAOIs can cause Postural Hypotension via ________ caused by accumulation of dopamine in cervical (neck) ganglia, where it acts as an ______ transmitter.

A
  1. sympathetic block
  2. inhibitory

(heart can no longer pump faster in response to postural change = insufficient blood to brain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

MAOIs can cause restlessness and insomnia due to _____ stimulation.

A

CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Why should MAOIs not be combined with drugs that enhance serotoninergic function, such as Pethidine?

A

May lead to: Hyperexcitability, increased muscular tone, myoclonus (jerking, involuntary movements), loss of consciousness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the interaction in the ‘Cheese’ reaction and what is it caused by?

A

A Drug-Food interaction arising from consuming cheeses and concentrated yeast products (i.e. marmite) together with MAOIs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the consequences of a ‘Cheese reaction’?

A

Acute hypertension, giving severe throbbing headache, and occasionally intracranial haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How can we try to prevent ‘cheese’ reaction?

A
  1. Avoid taking Cheese/conc. yeast food with MAOI

2. Use reversible MAO-A/B selective inhibitors (i.e. moclobemide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

‘Cheese’ reaction is _____ likely to occur with reversible, MAO-A/MAO-B selective(e.g. moclobemide) vs. irreversible, non-selective MAOIs

A

less

non selective = more enzymes blocked = worse reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the MOA of the cheese reaction?

A
  1. Amines such as tyramine (in cheese) accumulate when MAOs are inhibited.
  2. Tyramine is taken up into adrenergic terminals and competes with NA for vesicular compartment.
  3. Increased NA release into synapses. (sympathomimetic effect)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the MOA of the cheese reaction?

A
  1. Amines such as tyramine (in cheese) accumulate when MAOs are inhibited.
  2. Tyramine competes with NA for vesicular compartment.
  3. Increased NA release into synapses and a sympathomimetic effect.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

_________ are TCAs that are non-selective for SERT/NET.

A

Imipramine, Amitriptyline, nortriptyline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

________ is a TCA that is selective for NET.

A

Desipramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Nortriptyline is a _______ TCA that has _______ compared to amitriptyline and imipramine which leads to _______________.

A
  1. 2nd gen TCA
  2. milder side effects
  3. improved compliance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Nortriptyline is a _______ TCA that has _______ compared to amitriptyline and imipramine and improved compliance.

A
  1. 2nd gen TCA

2. milder side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
TCAs can lead to sedation due to ________ receptor antagonism. Tolerance to sedation can develop in ____ weeks
1. H1 Histamine | 2. 1-2wks
26
TCAs can lead to ______ due to α-adrenoceptor sympathetic block.
Postural Hypotension
27
What are some adverse effects of TCAs?
1. Sedation 2. Postural hypotension 3. Dry mouth, blurred vision, constipation
28
TCAs are _______ bound and eliminated via _______ route.
1. plasma protein | 2. Hepatic
29
SSRIs have greater ______ and fewer ______ when compared to TCAs.
1. 5-HT reuptake selectivity | 2. Fewer adverse effects
30
Place in therapy for TCAs?
For patients allergic to SSRIs
31
SSRIs have low affinity for α-adrenoceptors, leading to ________
Lack of cardiovascular effects, safer in overdose
32
SSRIs have low affinity for α-adrenoceptors, leading to ________
Lack of cardiovascular effects, safer in overdose
33
SSRIs have Lack of effect at _________ receptors, leading to ________
1. histamine | 2. Reduced sedation
34
SSRIs have Minimal anticholinergic side effects (e.g. dry mouth and constipation) due to __________
Low affinity for muscarinic cholinergic receptors
35
What is the main advantage of SSRIs?
SSRIs are safer in overdose and less side effects lead to better compliance. (compared to TCAs)
36
Adverse effects of TCAs lead to _______, which is seen at a lower frequency for SSRIs.
prescription of subtherapeutic doses.
37
Adverse effects of SSRIs include: ________, _______ and _________
Nausea Insomnia Sexual dysfunction
38
Nausea and vomiting (SSRIs) may be caused by __________________ when plasma levels of drug drop between doses.
Discontinuation/rebound symptoms of withdrawal (i.e. skipped dose)
39
Which SSRI still has histamine receptor antagonism and can cause sedation?
Citalopram
40
SSRIs can induce sexual dysfunction by increased stimulation of ________ and can be prevented by ___________, a _____ blocker.
1. 5-HT2 receptors 2. Cyproheptadine 3. 5-HT2
41
What is "Serotonin Syndrome" caused by?
Drug-drug interactions with other drugs increasing serotoninergic activity (e.g. MAOIs).
42
Effects of "Serotonin Syndrome" includes _____, _____ and _______
1. tremor 2. hyperthermia 3. cardiovascular collapse
43
For patients using SSRIs, only ____ get remission (respond).
2/3
44
Adverse effects of SSRIs are more pronounced when _____ and ______ the drug.
1. initiating | 2. discontinuing
45
NARIs have ________ selectivity than TCAs.
Greater NA reuptake
46
NARIs (i.e. Reboxetine) have approximately _______ fold selectivity for NA.
1000
47
NARIs have _______ adverse effects compared to TCAs and SSRIs
fewer
48
Maprotiline, an earlier NARI, had TCA-like adverse effects due to _______ and ______ receptor effects and occasionally caused _______.
1. α-adrenoceptor 2. histamine 3. seizures
49
Reboxetine can lead to _______ and ______ due to its anti-cholinergic effects.
1. Dry mouth | 2. Constipation
50
Reboxetine can lead to ________, likely due to increased noradrenergic effects in CNS.
insomnia
51
Reboxetine can lead to tachycardia, likely due to increased _______.
Increased availability of NA at sympathetic “fright, flight or fight” synapses.
52
Adverse effects of Reboxetine?
1. Dry mouth 2. Constipation 3. Insomnia 4. Tachycardia Note: new drug, adverse effects not well described
53
SNRIs have similar ______ reuptake inhibition profiles to non-selective TCAs.
dual 5-HT and NA
54
The Issue of additional receptor antagonism is controversial in SNRIs because ______?
We are not sure what are the other receptors SNRIs are binding to
55
3 SNRI examples in clinical use?
1. Venlafaxine 2. Desvenlafaxine(synthetic metabolite of venlafaxine) 3. Duloxetine
56
Venlafaxine has a different ________ compared to TCAs and _____ adverse effects than TCAs.
1. structure | 2. fewer
57
Venlafaxine claims to work _____ than other antidepressants and work better in _____ patients
1. slightly faster | 2. treatment-resistant
58
SNRIs have similar serotoninergic adverse effects similar to SSRIs, which include _______, _____, _______ and _______ when combined with other serotoninergic drugs and MAOIs.
1. Nausea 2. Insomnia 3. Sexual dysfunction 4. "Serotonin syndrome"
59
Withdrawal effects of SNRIs may be ______________ than SSRIs and TCAs.
more common and stronger
60
Mirtazapine is an _______ and specific ______ antidepressant (NaSSA). Antagonist of _______ autoreceptors and ____ receptor, among others.
1. norepinephrine 2. serotonin 3. adrenergic α2 4. 5-HT2C
61
Bupropion is an ______________ reuptake inhibitor (NDRI).
norepinephrine-dopamine
62
Agomelatine is an agonist of _______ receptors (also has antagonism at _________), less TCA / SSRI-associated side-effects and also helps in ______.
1. melatonin MT1 and MT2 2. 5-HT2C receptors 3. sleep disorders
63
Argomelatine is hypothetically safer to combine with MAOIs/SSRIs due to ____________.
lower risk of serotonin syndrome (antagonism of 5-HT)
64
Ketamine is a _____________ used as an anesthetic, currently evaluated for rapid-onset antidepressant effect.
glutamate NMDA receptor antagonist